Combined family history and polygenic score prediction of major depressive disorder
Wang, R.; Davies, H. L.; Lee, S. H.; Zvrskovec, J.; Hubel, C.; Kakar, S.; Malouf, C.; Meldrum, L.; Lin, Y.; Smith, I.; Kalsi, G.; Rogers, H. C.; Bristow, S.; Davies, M. R.; Lyall, D. M.; Young, A. H.; Cleare, A. J.; Davis, K. A. S.; Zahn, R.; Gault, V. A.; Dowey, L. R. C.; Price, R. K.; Thomas, K. G.; Walters, J. T. R.; Smith, D. J.; Armour, C.; Jones, I. R.; Kingston, N.; Bradley, J. R.; McIntosh, A. M.; NIHR BioResource consortium, ; The GLAD Study, ; Hotopf, M.; Coleman, J. R.; Vassos, E.; Eley, T.; Iniesta, R.; Breen, G.
Show abstract
ImportanceMajor depressive disorder (MDD) is a complex psychiatric disorder influenced by genetic, social, and environmental factors. Family history, genome-wide polygenic scores, and childhood trauma are key predictors of MDD onset with distinct contributions. ObjectiveThis study modelled the combined effects of family history of multiple psychiatric disorders, polygenic scores of multiple traits, and childhood trauma, alongside sociodemographic factors on MDD diagnosis and number of episodes. We aimed to build and externally validate predictive models for MDD risk and severity. ParticipantsWe used data from the Genetic Links to Anxiety and Depression Study and other NIHR BioResource studies (GLAD+) and UK Biobank (UKB) collected between 2016 and 2023. Outcomes and measurementsMDD diagnosis followed DSM-5 criteria using online questionnaire data. Family history (Yes/No) was reported for up to 22 psychiatric disorders. Polygenic scores were calculated based on genome-wide association studies (n=22). Participants answered the five-item childhood trauma screener. We used elastic net regression with nested cross-validation to select the best predictors. ResultsIn GLAD+ (9,927 MDD cases, 4,452 controls), family history explained 17% of the MDD variance, followed by childhood trauma (11%), sociodemographics (10%), and polygenic scores (7%), resulting in 33% of the MDD variance (AUC-ROC=0.84). In UKB (40,667 MDD cases, 70,755 controls), family history explained 13% of the MDD variance, childhood trauma (7%), sociodemographics (6%), and polygenic scores (4%). Combined together, the predictors explained 23% of the variance (AUC-ROC=0.74). The top five individual predictors were family history of depression, childhood trauma, female sex, family history of anxiety, and the MDD polygenic score in both cohorts. The predictive models were externally well-validated across GLAD+ and UKB obtaining comparable predictive performance. Finally, when combined, the predictors explained 26% and 12% of the variance in the number of MDD episodes in GLAD+ and UKB respectively. ConclusionsIntegrating family history, PRSs, ChT, and sociodemographic factors can predict risk of an MDD diagnosis and its recurrent course. This model may help identify individuals at high risk for depression in clinical settings, assess its severity, enable early diagnosis and potentially personalize treatment.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Estimating the impact of transmitted and non-transmitted psychiatric and neurodevelopmental polygenic scores on youth emotional problems 96%
- Genetics of Major Depressive Disorder in a Homogeneous Population with Uniform Phenotyping 95%
- Cross-phenotype relationship between opioid use disorder and suicide attempts: new evidence from polygenic association and Mendelian randomization analyses 95%
Similar papers in this journal
- Are psychiatric disorders risk factors for COVID-19 susceptibility and severity? a two-sample, bidirectional, univariable and multivariable Mendelian Randomization study 96%
- Distinguishing clinical and genetic risk factors for suicidal ideation and behavior in a diverse hospital population 95%
- Genetic liability to major psychiatric disorders contributes to multi-faceted quality of life outcomes in children and adults 95%
Similar papers in this journal
Similar papers in this journal
- Decoding Treatment Choice: Genetic and Phenotypic Analyses of Long-term Antidepressant Acceptability 93%
- Thinner cortex is associated with psychosis onset in individuals at Clinical High Risk for Developing Psychosis: An ENIGMA Working Group mega-analysis 92%
- Evidence for a serotonergic subtype of major depressive disorder: A NeuroPharm-1 study. 92%
Similar papers in this journal
- Reproducible Risk Loci and Psychiatric Comorbidities in Anxiety: Results from ~200,000 Million Veteran Program Participants 95%
- Decoding shared versus divergent transcriptomic signatures across cortico-amygdala circuitry in PTSD and depressive disorders 94%
- Interplay of ADHD polygenic liability with birth-related, somatic and psychosocial factors in ADHD - a nationwide study 91%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.